Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.05 EUR
−3.45 M EUR
60.09 K EUR
37.35 M
About AWAKN LIFE SCIENCES CORP.
Sector
Industry
CEO
Anthony Tennyson
Website
Headquarters
Toronto
FIGI
BBG01248T5L6
Awakn Life Sciences Corp. is a clinical-stage biotechnology company, which engages in developing therapeutics targeting addiction. The firm develops next generation of psychedelic drugs, therapies, and enabling technologies to treat Addiction. The company was founded by Anthony Tennyson, Jonathan Held, Dr. Benjamin Sessa and George Scorsis in 2020 and is headquartered in Toronto, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 954 is 0.08 EUR — it has increased by 19.55% in the past 24 hours. Watch AWAKN LIFE SCIENCES CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange AWAKN LIFE SCIENCES CORP stocks are traded under the ticker 954.
954 stock has risen by 72.83% compared to the previous week, the month change is a 78.65% rise, over the last year there was no change in AWAKN LIFE SCIENCES CORP price.
954 stock is 16.35% volatile and has beta coefficient of −0.26. Track AWAKN LIFE SCIENCES CORP stock price on the chart and check out the list of the most volatile stocks — is AWAKN LIFE SCIENCES CORP there?
Today AWAKN LIFE SCIENCES CORP has the market capitalization of 3.80 M, it has increased by 1.41% over the last week.
Yes, you can track AWAKN LIFE SCIENCES CORP financials in yearly and quarterly reports right on TradingView.
AWAKN LIFE SCIENCES CORP is going to release the next earnings report on Dec 12, 2024. Keep track of upcoming events with our Earnings Calendar.
954 net income for the last quarter is −241.46 K EUR, while the quarter before that showed −370.78 K EUR of net income which accounts for 34.88% change. Track more AWAKN LIFE SCIENCES CORP financial stats to get the full picture.
No, 954 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has 6.00 employees. See our rating of the largest employees — is AWAKN LIFE SCIENCES CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AWAKN LIFE SCIENCES CORP EBITDA is −1.74 M EUR, and current EBITDA margin is −4.47 K%. See more stats in AWAKN LIFE SCIENCES CORP financial statements.
Like other stocks, 954 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AWAKN LIFE SCIENCES CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AWAKN LIFE SCIENCES CORP technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AWAKN LIFE SCIENCES CORP stock shows the neutral signal. See more of AWAKN LIFE SCIENCES CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.